Regenxbio (RGNX) Shares Outstanding (Weighted Average) (2014 - 2025)

Regenxbio's Shares Outstanding (Weighted Average) history runs 12 years deep, the most recent figure standing at $51.6 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 4.17% year-over-year to $51.6 million; the TTM figure through Dec 2025 stood at $51.6 million (up 4.17% YoY), while the FY2025 annual figure was $51.6 million, up 4.17% from the prior year.
• Shares Outstanding (Weighted Average) was $51.6 million for Q4 2025 at Regenxbio, roughly flat from $51.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $51.7 million in Q3 2025 to a low of $41819.0 in Q1 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $28.2 million across 5 years, with a median of $43.3 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Weighted Average) sank 99.89% in 2021, then jumped 101155.13% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $42.4 million in 2021, then rose by 1.68% to $43.2 million in 2022, then gained by 1.35% to $43.7 million in 2023, then increased by 13.2% to $49.5 million in 2024, then rose by 4.17% to $51.6 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $51.6 million (Q4 2025), $51.7 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.